Martin Tolstrup
Overview
Explore the profile of Martin Tolstrup including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
134
Citations
3363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Timmermann A, Johansen I, Tolstrup M, Heilmann C, Budtz-Jorgensen E, Tolstrup J, et al.
Environ Res
. 2024 Sep;
263(Pt 1):120039.
PMID: 39326653
Introduction: Per- and polyfluoroalkyl substances (PFASs) have immunotoxic effects in children while studies in adults, including recent studies on the SARS-CoV-2 vaccine response have been less consistent. In a cohort...
2.
Cham L, Rosas-Umbert M, Lin L, Tolstrup M, Sogaard O
Cell Physiol Biochem
. 2024 Jul;
58(4):322-335.
PMID: 39074350
Background/aims: Immune cells are reported to upregulate CD47 during infection, however, the role of CD47 in innate and adaptive immune cells remains unclear. Methods: To bridge this knowledge gap, we...
3.
Mahr A, Bennett-Boehm M, Rothemejer F, Weber I, Regan A, Franzen J, et al.
Sci Rep
. 2024 Jun;
14(1):14595.
PMID: 38918496
There are two known mechanisms by which natural killer (NK) cells recognize and kill diseased targets: (i) direct killing and (ii) antibody-dependent cell-mediated cytotoxicity (ADCC). We investigated an indirect NK...
4.
Reekie J, Stovring H, Nielsen H, Johansen I, Benfield T, Wiese L, et al.
Int J Infect Dis
. 2024 May;
146:107111.
PMID: 38801970
Objectives: This study aimed to compare antibody trajectories among individuals with SARS-CoV-2 hybrid and vaccine-induced immunity. Methods: Danish adults receiving three doses of BTN162b2 or mRNA-1237 were included prior to...
5.
Juhl A, Dietz L, Sogaard O, Reekie J, Nielsen H, Johansen I, et al.
J Infect Dis
. 2024 Apr;
230(3):e605-e615.
PMID: 38687181
Background: Within a year of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, vaccines inducing a robust humoral and cellular immune response were implemented worldwide. However, emergence of novel...
6.
Cham L, Lin L, Tolstrup M, Sogaard O
STAR Protoc
. 2023 Dec;
5(1):102777.
PMID: 38133956
Many immunological treatment strategies for reducing the HIV-1 reservoir and enhancing adaptive immunity aim at activating the human plasmacytoid dendritic cells (pDCs). Here, we present a protocol for pDC enrichment,...
7.
Hvidt A, Guo H, Andersen R, Lende S, Vibholm L, Sogaard O, et al.
BMC Immunol
. 2023 Nov;
24(1):45.
PMID: 37974069
Background: SARS-CoV-2 remains a world-wide health issue. SARS-CoV-2-specific immunity is induced upon both infection and vaccination. However, defining the long-term immune trajectory, especially after infection, is limited. In this study,...
8.
Kuczkowska K, Bjerkan L, Stubsrud E, Husbyn H, Chellappa S, Hauge A, et al.
Sci Rep
. 2023 Nov;
13(1):18902.
PMID: 37919366
Throughout the COVID-19 pandemic, several variants of concern (VoC) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have evolved, affecting the efficacy of the approved COVID-19 vaccines. To address...
9.
Ammitzboll C, Thomsen M, Andersen J, Jensen J, Bayarri-Olmos R, Garred P, et al.
Clin Exp Rheumatol
. 2023 Oct;
42(1):157-165.
PMID: 37877429
Objectives: To investigate the effect of COVID-19 mRNA revaccination (two doses) on the antibody response in patients with rheumatic diseases (RD) who were initial vaccine non-responders. Further, to examine if...
10.
Discovery of neutralizing SARS-CoV-2 antibodies enriched in a unique antigen specific B cell cluster
Lende S, Barnkob N, Hansen R, Bansia H, Vestergaard M, Rothemejer F, et al.
PLoS One
. 2023 Sep;
18(9):e0291131.
PMID: 37729215
Despite development of effective SARS-CoV-2 vaccines, a sub-group of vaccine non-responders depends on therapeutic antibodies or small-molecule drugs in cases of severe disease. However, perpetual viral evolution has required continuous...